Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases

Abstract Background Acute-on-chronic liver failure (ACLF) is a severe clinical condition for which liver transplantation (LT) is the only curative option. However, there are little published data on risk factors and outcomes of LT for ACLF. Methods The objective of this study was to analyze preopera...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of surgical research 2013-08, Vol.183 (2), p.936-943
Main Authors: Duan, Bin-Wei, MD, Lu, Shi-Chun, PhD, MD, Wang, Meng-Long, MD, Liu, Jin-Ning, MD, Chi, Ping, MD, Lai, Wei, MD, Wu, Ju-Shan, MD, Guo, Qing-Liang, MD, Lin, Dong-Dong, MD, Liu, Yuan, MD, Zeng, Dao-Bing, MD, Li, Chuan-Yun, MD, Meng, Qing-Hua, MD, Ding, Hui-Guo, MD, Chen, Xin-Yue, MD, Liao, Hui-Yu, MD, Ma, Lie-Qing, MD, Chen, Yu, MD, Zhang, Jing, MD, Xiang, Hai-Ping, MD, Duan, Zhong-Ping, MD, Li, Ning, MD
Format: Article
Language:English
Subjects:
Acute-on-chronic liver failure
Adult
End Stage Liver Disease - mortality
End Stage Liver Disease - surgery
Female
Humans
Liver Failure, Acute - mortality
Liver Failure, Acute - surgery
Liver Transplantation
Living Donors
Male
Middle Aged
Model for end-stage liver disease (MELD) score
Retrospective Studies
Surgery
Survival Rate
Tissue Donors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Acute-on-chronic liver failure (ACLF) is a severe clinical condition for which liver transplantation (LT) is the only curative option. However, there are little published data on risk factors and outcomes of LT for ACLF. Methods The objective of this study was to analyze preoperative, intraoperative, postoperative, and overall survival data on 100 consecutive cases with ACLF in order to try to determine for which patients LT are futile. Results One hundred consecutive patients with pathology-confirmed ACLF who underwent LT from June 2004 to September 2012 were enrolled. The preoperative data showed that all patients were in a serious condition with a median high model for end-stage liver disease (MELD) score of 32, total bilirubin of 440.20 umol/L, international normalized ratio (INR) of 3.012, and at least one organ dysfunction as assessed by a Sequential Organ Failure Assessment (SOFA) score of ≥9. The patients had either deceased or a living donor LT with an overall mortality of 20%. The 1-, 3-, and 5-year cumulative survival rates were 76.8%, 75.6%, and 74.1%, respectively, and graft 1-, 3-, and 5-y accumulative survival rates were 73.3%, 72.1%, and 70.6%, respectively. However, the area under receiver operating characteristic of SOFA score, MELD score, as well as Child-Pugh score were 0.552, 0.547, and 0.547, respectively. Conclusions Both deceased and living donor LT are effective therapeutic options for patients with ACLF and the short- and long-term survival rates are encouraging. It is important to conduct more prospective and multi-center studies to define preoperatively which patients would benefit from LT.
ISSN:0022-4804
1095-8673
DOI:10.1016/j.jss.2013.03.008